Harihar Medical Agencies Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 29-06-2024
- Paid Up Capital ₹ 1.00 Cr
as on 29-06-2024
- Company Age 14 Year, 15 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.13 Cr
as on 29-06-2024
- Revenue 2303.55%
(FY 2021)
- Profit 9381.62%
(FY 2021)
- Ebitda 4007.24%
(FY 2021)
- Net Worth 1416.38%
(FY 2021)
- Total Assets 682.27%
(FY 2021)
About Harihar Medical Agencies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹3.13 Cr.
Nitish Kumar, Ramesh Sharma, and Baby Sharma serve as directors at the Company.
- CIN/LLPIN
U24232JH2010PTC014444
- Company No.
014444
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Oct 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jharkhand
Industry
Company Details
- Location
Ranchi, Jharkhand, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Harihar Medical Agencies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Baby Sharma  | Managing Director | 05-Oct-2010 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nitish Kumar | Director | 05-Oct-2010 | Current |
| Ramesh Sharma | Director | 05-Oct-2010 | Current |
Financial Performance and Corporate Structure Insights of Harihar Medical Agencies.
Harihar Medical Agencies Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 2303.55% increase. The company also saw a substantial improvement in profitability, with a 9381.62% increase in profit. The company's net worth Soared by an impressive increase of 1416.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Harihar Medical Agencies?
In 2021, Harihar Medical Agencies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hyeto Pharmaceuticals Private Limited
Active 17 years 10 monthsRamesh Sharma and Baby Sharma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 01 Jan 2011 | ₹3.13 Cr | Open |
How Many Employees Work at Harihar Medical Agencies?
Unlock and access historical data on people associated with Harihar Medical Agencies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Harihar Medical Agencies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Harihar Medical Agencies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
